Sign in to continue:

Friday, March 27th, 2026

TXO Partners, L.P. 2025 Annual Report Amendment (10-K/A): Financial Statements, Revenues, and Key Disclosures




TXO Partners, L.P. Files Form 10-K/A: Key Highlights for Investors

TXO Partners, L.P. Files Amended Annual Report (Form 10-K/A) for Fiscal Year 2025

Key Points from the Filing

  • Filing Overview: TXO Partners, L.P. (“TXO Partners”) has filed Amendment No. 1 to its Annual Report on Form 10-K for the year ended December 31, 2025. The amendment addresses certain updates and corrections but does not update or restate information from the original filing, nor does it reflect any events that have occurred after the original filing date of February 26, 2026.
  • Financial Statements: The Amendment includes the full text of Item 8, “Financial Statements and Supplementary Data,” along with new certifications from the Principal Executive Officer and Principal Financial Officer, and updated inline XBRL exhibits.
  • Outstanding Units: As of February 26, 2026, there were 55,242,507 Common Units outstanding, a key detail for investors tracking dilution and ownership structure.
  • Exchange Listing: TXO Partners’ Common Units trade under the symbol “TXO” on the New York Stock Exchange (XNYS).
  • Issuer Status: The company is not a well-known seasoned issuer, nor is it a shell company. TXO Partners is classified as an “Emerging Growth Company” under SEC definitions, which may impact its disclosure obligations and transition relief for certain accounting standards.
  • Internal Controls: The company did not include an auditor attestation report on the effectiveness of internal control over financial reporting under Section 404(b) of Sarbanes-Oxley.

Detailed Financial Highlights

Financial Metric 2025 (\$000) 2024 (\$000)
Total Assets \$1,354,903 \$1,030,841
Total Liabilities & Partners’ Capital \$1,354,903 \$1,030,841
Current Assets \$95,334 \$64,447
Partners’ Capital \$691,732 \$609,416
Long-term Debt \$291,100 \$157,100
Other Liabilities (Current & Noncurrent) \$218,154 (2025, current)
\$534 (2025, noncurrent)
\$197,988 (2024, current)
\$1,062 (2024, noncurrent)
Derivative Assets (Current & Noncurrent) \$18,276 (2025, current)
\$5,576 (2025, noncurrent)
\$6,412 (2024, current)
\$2,065 (2024, noncurrent)
Revenues (Year Ended Dec 31, 2025) \$380,718 \$282,810

Shareholder and Price-Sensitive Information

  • No Financial Restatement: The Amendment does not reflect any financial restatements or corrections of previously issued financial statements, nor does it trigger any recovery analysis for incentive-based compensation under SEC rules.
  • Growth and Leverage: The partnership saw a significant increase in both total assets and total liabilities, notably long-term debt rising from \$157.1 million to \$291.1 million year-over-year. This increase in leverage may be price-sensitive, as it could impact future distributions and the risk profile of the partnership.
  • Revenue Growth: Revenues grew sharply from \$282.8 million in 2024 to \$380.7 million in 2025, indicating a strong operational performance that investors should note.
  • Emerging Growth Company Status: This status allows TXO Partners to take advantage of certain regulatory and reporting reliefs, which may affect the transparency and comparability of its financial reporting relative to more mature peers.
  • No Documents Incorporated by Reference: The Amendment does not incorporate any additional documents by reference, focusing solely on the financial reporting package.
  • Control Environment: The absence of an auditor attestation on internal controls may be a concern for some investors, as it could indicate a higher risk profile regarding financial reporting integrity.

Potential Share Price Impact

The combination of strong revenue growth, a substantial increase in long-term debt, and the absence of any financial restatement or material weaknesses in internal control (as reported) are all key factors that may influence investor sentiment and TXO Partners’ trading price.

  • Positive Drivers: Revenue expansion and asset growth signal operational momentum.
  • Potential Risks: Increased leverage and absence of an auditor attestation on internal controls may raise concerns about financial risk and reporting robustness.

Conclusion

Investors should closely monitor TXO Partners, L.P. for further updates, particularly regarding its increased leverage, growth trajectory, and internal control disclosures as it continues to operate under the regulatory framework for emerging growth companies.


Disclaimer: This article is for informational purposes only and does not constitute investment advice. Readers should consult their own financial advisor before making investment decisions. The information is based on the company’s public SEC filing and may be subject to change or interpretation. The author and publisher accept no liability for actions taken in reliance on this information.




View TXO Partners, L.P. Historical chart here



Cardiff Oncology Reports Positive Phase 2 Results for Onvansertib in RAS-Mutated mCRC and Provides 2025 Financial Update

Cardiff Oncology Reports Full Year 2025 Results & Business U...

Armada Acquisition Corp. III: Focused SPAC Targeting FinTech, SaaS, and AI Market Growth Opportunities

AACI Acquisition Corp. Annual Report: Key Investor Insights ...

   Ad